H35.079 Retinal telangiectasis, unspecified eye

Name of the Condition

• Retinal Telangiectasis, Unspecified Eye

Summary

Retinal telangiectasis is a condition characterized by abnormal dilation or leakage of retinal blood vessels. When affecting an unspecified eye, it may impact vision depending on the location and severity of vascular changes.

Causes

The exact cause is often unknown, but it may involve vascular abnormalities or genetic factors. It is not typically linked to infection or lifestyle choices.

Risk Factors

• Age, particularly in middle to older adulthood.
• Family history of retinal vascular diseases.
• Underlying systemic conditions affecting blood vessels.

Symptoms

• Blurred or distorted vision.
• Difficulty with fine detail or reading.
• Metamorphopsia (visual distortion).
• Potential central vision loss in advanced cases.

Diagnosis

A comprehensive eye examination by an ophthalmologist is required. Imaging such as optical coherence tomography (OCT) or fluorescein angiography may be used to assess vascular changes.

Treatment Options

• Management focuses on symptom control and preventing progression.
• Anti-VEGF injections may reduce retinal swelling.
• Laser therapy can seal leaking vessels in some cases.
• Low-vision aids may assist with visual function.

Prognosis and Follow-Up

Prognosis varies based on severity and response to treatment. Regular follow-up is recommended to monitor for progression or complications.

Complications

• Vision loss due to retinal damage.
• Macular edema (swelling in the central retina).
• Potential for retinal detachment in severe cases.

Lifestyle & Prevention

• No specific preventive measures are known, but managing systemic conditions (e.g., diabetes) may reduce risk.
• Regular eye exams are advised for early detection.

When to Seek Professional Help

Seek care if experiencing sudden vision changes, blurred vision, or distortion, as these may indicate progression.

Tips for Medical Coders

Document the affected eye (right, left, or unspecified) and any associated findings (e.g., leakage, dilation) to support code assignment. Ensure clinical documentation aligns with the unspecified eye designation when no specific eye is identified.